Protriptyline
Protriptyline, sold under the brand name Vivactil among others, is a tricyclic antidepressant (TCA), specifically a secondary amine, indicated for the treatment of depression and attention-deficit hyperactivity disorder (ADHD). Uniquely among most of the TCAs, protriptyline tends to be energizing instead of sedating, and is sometimes used for narcolepsy to achieve a wakefulness-promoting effect.
Clinical data | |
---|---|
Trade names | Vivactyl, others |
Other names | Amimethyline; Protriptyline hydrochloride; MK-240 |
AHFS/Drugs.com | Monograph |
MedlinePlus | a604025 |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 77–93% |
Protein binding | 92% |
Metabolism | Hepatic |
Elimination half-life | 54–92 hours |
Excretion | Urine: 50% Feces: minor |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.474 |
Chemical and physical data | |
Formula | C19H21N |
Molar mass | 263.384 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
TCAs including protriptyline are also used to reduce the incidence of recurring headaches such as migraine, and for other types of chronic pain.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.